Justin Meiklem

Vancouver, BC and Rehovot, Israel, September 3, 2026– BioHarvest Sciences Inc. (Nasdaq: BHST) (FSE: 8MV0), a leader in Botanical Synthesis technology and sustainable plant-based molecule development today announced its intention to offer its ordinary shares on the Tel Aviv Stock Exchange (TASE) and to become dual-listed for trade on both the Nasdaq and TASE markets. 

Vancouver, British Columbia and Rehovot, Israel – August 11, 2026 - BioHarvest Sciences Inc (Nasdaq: BHST) (FSE: 8MV0), a leader in Botanical Synthesis technology and sustainable plant-based molecule development, today announced results from the second quarter and six months of 2026.   Dr. Zaki Rakib, Chief Executive Officer of BioHarvest, stated, “We are extremely pleased to have signed a manufacturing agreement this

Vancouver, British Columbia and Rehovot, Israel- August 11, 2026 – BioHarvest Sciences Inc (Nasdaq: BHST) (FSE: 8MV0), a leader in Botanical Synthesis technology and sustainable plant-based molecule development, today announced an exclusive manufacturing and supply agreement that secures production of a rare, endangered, fragrance plant cell culture, extending terms of the original Agreement (“the Agreement”) with its

Grant to partially fund research that will enable faster development, with a higher probability of success, of new plant-based compounds (precision botanics) for the benefit of BioHarvest’s CDMO customers and partners Vancouver, British Columbia and Rehovot, Israel- – BioHarvest Sciences Inc (NASDAQ: BHST) (FSE: 8MV0), a leader in Botanical Synthesis technology and sustainable plant-based molecule development, today

Vancouver, British Columbia and Rehovot, Israel – July 13, 2026 – BioHarvest Sciences Inc (NASDAQ: BHST) (FSE: 8MV0), a leader in Botanical Synthesis technology and sustainable plant-based molecule development, today announced that its Chief Executive Officer, Zaki Rakib, will participate in a fireside chat at the upcoming Maxim Health, Wellness & Longevity Conference, to be held